Management of Cancer-Associated Venous Thromboembolism in the Emergency Department.
Patients with cancer are at increased risk of venous thromboembolism, and emergency physicians can play a significant role in addressing one of the leading causes of morbidity and mortality in this patient population. However, there are no comprehensive guidelines addressing the approach to cancer-associated venous thromboembolism in the emergency department. Here, we review the guidelines put forth by various national and international cancer societies and highlight how emergency physicians can help institute appropriate treatment and prevent the recurrence of venous thromboembolism in cancer patients. We also address areas of controversy and highlight topics that require further research.
Medical Scientist Training Program, University of California, San Diego School of Medicine, La Jolla, CA.
Rahul V
RV
Nene
Department of Emergency Medicine, University of California, San Diego School of Medicine, San Diego, CA. Electronic address: cjcoyne@ucsd.edu.
Christopher J
CJ
Coyne
D000925:Anticoagulants / Q000627:therapeutic use*; D000075202:Contraindications; D004636:Emergency Service, Hospital; D017408:Guidelines as Topic; D006495:Heparin, Low-Molecular-Weight / Q000627:therapeutic use*; D006801:Humans; D009369:Neoplasms / Q000150:complications*; D017410:Practice Guidelines as Topic; D012008:Recurrence; D012307:Risk Factors; D055502:Secondary Prevention / Q000379:methods; D054556:Venous Thromboembolism / Q000188:drug therapy* / Q000517:prevention & control; D014812:Vitamin K / Q000037:antagonists & inhibitors*
D000925:Anticoagulants; D006495:Heparin, Low-Molecular-Weight; D014812:Vitamin K